Health ❯ Healthcare ❯ Medical Research ❯ Clinical Trials

Breast Cancer

Preoperative MRI Fails to Improve Outcomes in Early HR-Negative Breast Cancer

Five-year randomized data presented at SABCS show outcomes matching standard care without added imaging.

Tucatinib Added to First-Line HER2 Maintenance Prolongs Progression-Free Survival in Phase 3 Trial

Roche’s Giredestrant Cuts Early Breast Cancer Recurrence 30% in Phase III Trial

Arvinas’ Vepdegestrant Delays Breast Cancer Progression Longer Than Faslodex